Search results
Raymond James Cuts HLS Therapeutics (TSE:HLS) Price Target to C$4.00
ETF DAILY NEWS· 21 hours agoHLS Therapeutics (TSE:HLS – Free Report) had its target price cut by Raymond James from C$5.00 to C$4.00 in a report issued on Friday morning, BayStreet.CA reports. A number of other research ...
Rytary interactions: Other medications, alcohol, and more
Medical News Today· 4 days ago) is a brand-name oral capsule prescribed for Parkinson’s disease and parkinsonism. Rytary has...
Teva and Medincell's schizophrenia drug meets main goal of late-stage study
Reuters· 6 days agoIsrael-based Teva Pharmaceuticals , and French partner Medincell said on Wednesday their injectable...
Neupro interactions: Other medications, alcohol, and more
Medical News Today· 7 days agoNeupro is a brand-name drug used to treat Parkinson's and restless leg syndrome. Discover drug...
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript May 7, 2024...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript May 8, 2024 Vanda...
Earnings call: Vanda Pharmaceuticals reports mixed Q1 results, plans growth
Investing.com· 5 days agoVanda (NASDAQ: VNDA ) Pharmaceuticals Inc. (VNDA) discussed its performance in the first quarter of...
D.C. biotech mulling sweetened acquisition offer - Washington Business Journal
The Business Journals· 6 days agoPak LLC. Vanda disclosed last month it had rejected unsolicited acquisition overtures from the...
Wells man who attacked NYPD officers with knife had untreated mental illness, attorneys say
Portland Press Herald, Maine via Yahoo News· 7 days agoMay 6—Trevor Bickford's first psychotic symptom came in spring 2022 when he felt like his soul was being ripped from his body. Over the next few months, more hallucinations emerged: visions ...
Q1 2024 Vanda Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoFanapt LAI could reach the U.S. market after 2026, and their pending patent applications that, if issued, could extend exclusivity into the 2040s. This is a key differentiation from some currently ...
